These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

82 related articles for article (PubMed ID: 39774)

  • 21. Pharmacological profile of dopamine receptor agonists as studied by brain dialysis in behaving rats.
    Imperato A; Tanda G; Frau R; Di Chiara G
    J Pharmacol Exp Ther; 1988 Apr; 245(1):257-64. PubMed ID: 3258912
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Ziprasidone (CP-88,059): a new antipsychotic with combined dopamine and serotonin receptor antagonist activity.
    Seeger TF; Seymour PA; Schmidt AW; Zorn SH; Schulz DW; Lebel LA; McLean S; Guanowsky V; Howard HR; Lowe JA
    J Pharmacol Exp Ther; 1995 Oct; 275(1):101-13. PubMed ID: 7562537
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Pharmacological profile of the new potent neuroleptic ocaperidone (R 79,598).
    Megens AA; Awouters FH; Meert TF; Schellekens KH; Niemegeers CJ; Janssen PA
    J Pharmacol Exp Ther; 1992 Jan; 260(1):146-59. PubMed ID: 1370538
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Central action of adrenaline.
    Jagiełło-Wójtowicz E
    Acta Physiol Pol; 1981; 32(2):169-80. PubMed ID: 7196677
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Psychotropic activity of N-methyl-2-amino-4-phosphonobutyric acid (N-methyl AP4).
    Zalewska A; Winnicka MM; Wiśniewski K
    Pol J Pharmacol; 1996; 48(4):415-23. PubMed ID: 9112682
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Differentiating the action of cataleptogenic bodies (author's transl)].
    Menge HG; Brand U
    Arzneimittelforschung; 1978; 28(9):1506-7. PubMed ID: 38810
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Interaction of benzodiazepines with neuroleptics at central dopamine neurons.
    Keller HH; Schaffner R; Haefely W
    Naunyn Schmiedebergs Arch Pharmacol; 1976 Jul; 294(1):1-7. PubMed ID: 12477
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Brain homovanillic acid: regional changes over time with antipsychotic drugs.
    Bowers MB; Rozitis A
    Eur J Pharmacol; 1976 Sep; 39(1):109-15. PubMed ID: 9303
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Acute and chronic effects of neuroleptic drugs on plasma and brain homovanillic acid in the rat.
    Kendler KS; Davis KL
    Psychiatry Res; 1984 Sep; 13(1):51-8. PubMed ID: 6151204
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The neuropharmacological actions of amoxapine.
    Greenblatt EN; Lippa AS; Osterberg AC
    Arch Int Pharmacodyn Ther; 1978 May; 233(1):107-35. PubMed ID: 28699
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Influence of psychotropic drugs and beta-diethylaminoethyl-diphenylpropylacetate (SKF 525-A) on mescaline-induced behavior and on tissue levels of mescaline in mice.
    Shah NS
    Biochem Pharmacol; 1976 Mar; 25(5):591-7. PubMed ID: 8055
    [No Abstract]   [Full Text] [Related]  

  • 32. Amperozide--a new putatively antipsychotic drug with a limbic mode of action on dopamine mediated behaviour.
    Gustafsson B; Christensson E
    Pharmacol Toxicol; 1990; 66 Suppl 1():12-7. PubMed ID: 1968250
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effects of aminooxyacetic acid and baclofen on catalepsy, striatal homovanillic acid increase and antinociception caused by methadone in rats.
    Kääriäinen K; Vikberg P
    Acta Pharmacol Toxicol (Copenh); 1976; 39(5):536-44. PubMed ID: 990037
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Increased effect of apomorphine on homovanillic acid in rats terminated from chronic haloperidol.
    Smith RC; Narasimhachari N; Davis JM
    J Neural Transm; 1978; 42(2):159-62. PubMed ID: 650206
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The effects of morphine on the accumulation of homovanillic and 5-hydroxyindoleacetic acids in the choroid plexus of rats.
    Huang JT; Wajda IJ
    Br J Pharmacol; 1977 Jul; 60(3):363-7. PubMed ID: 890207
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Correlation between neuroleptic-induced suppression of stereotyped behaviour and HVA concentrations in rat brain.
    Rollema H; Westerink BH; Grol CJ
    J Pharm Pharmacol; 1976 Apr; 28(4):321-3. PubMed ID: 6728
    [No Abstract]   [Full Text] [Related]  

  • 37. [Behavioral changes induced by psychotropic substances in experimental animals].
    Kreiskott H
    Arzneimittelforschung; 1974 Sep; 24(9):1294-7. PubMed ID: 4479795
    [No Abstract]   [Full Text] [Related]  

  • 38. The effect of narcotic analgesics on the homovanillic acid content of rat nucleus caudatus.
    Ahtee L; Kääriäinen I
    Eur J Pharmacol; 1973 May; 22(2):206-8. PubMed ID: 4736670
    [No Abstract]   [Full Text] [Related]  

  • 39. [The characteristics of the neuropsychotropic activity of bromantane in laboratory animals].
    Morozov IS; Klimova NV; Karpova TD; Shestopalov SS
    Eksp Klin Farmakol; 1999; 62(2):3-6. PubMed ID: 10340117
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The influence of cerebral 5-hydroxytryptamine on catalepsy induced by brain-amine depleting neuroleptics or by cholinomimetics.
    Fuenmayor LD; Vogt M
    Br J Pharmacol; 1979 Oct; 67(2):309-18. PubMed ID: 40649
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.